Gabelli Health & Wellness:GRX

    Manage Alerts

    Overview

    As of 10/11/2019

     Share
    Price
    NAVPremium/
    Discount
    Current$10.17$11.70-13.08%
    52 Wk Avg$10.33$11.95-13.56%
    52 Wk High$10.84$12.65-10.03%
    52 Wk Low$8.76$10.29-16.47%
    Regular Distribution TypeIncome Only
    Distribution Rate5.41%
    Distribution Amount$0.1400
    Distribution FrequencyQuarterly
    Past performance is no guarantee of future results.

    Basic Information

    Investment Objective

    The Fund seeks long term capital growth through investment in equity and debt securities issued by the healthcare and wellness industries

    Capital Structure

    As of 10/11/2019

    Total Net Assets:$294.743M
    Total Common Assets:$227.708M
    Common Shares Outstanding:19,663,860
    Leverage

    As of 6/28/2019

    Preferred Share Assets: $67.000M
    Type of Preferred: Cumulative Preferred Shares
    Total Debt (USD):
    Structural Leverage (USD): $67.000M
    Structural Leverage (%): 23.00%
    Effective Leverage (USD): $67.000M
    Effective Leverage (%): 23.00%
    Annual Expense Ratios

    As of 12/31/2018

      Per Common Share
    Management Fees1.27%
    Other Expenses:0.28%
    Baseline Expense: 1.55%
    Interest Expense:0.00%
    Total: 1.55%
    Fund Management

    Fund Sponsor
    Gabelli Funds Inc

    Portfolio Managers
    Kevin Dreyer (18 Jun 2010) / Mario J Gabelli (28 Jun 2007) / Jeffrey Jonas (18 Jun 2010)

    Basics
    Category: US Equity-Health/Biotech
    Ticker: GRX
    NAV Ticker: XXGRX
    Average Daily Volume (shares): 39,000
    Average Daily Volume (USD): $0.401M
    Inception Date: 6/19/2007
    Inception Share Price: $8.20
    Inception NAV: $8.00
    Tender Offer: No
    Term: No
    Fiscal Year End: December 31
    Third Party Links & Reports

    Distributions

    As of 10/11/2019

    Past performance is no guarantee of future results.
    Distribution History

    Enter declared start and end dates to display distribution history below. Income, Long Gain, Short Gain and ROC breakdowns will only be shown for the past year.

    Declared Date Payable Date Ex Date Distrib Amount Income Long Gain Short Gain ROC

    *Indicates a Special Distribution: A distribution disbursed in addition to the normal distributions paid out by the company.

    Key Information Regarding Distributions
    Avg. Earnings Per Share:
    As of 6/30/2019
    -$0.0138
    Annualized Distribution Rate on NAV:
    As of 10/11/2019
    4.70%
    Total Return on NAV (12 months):
    As of 10/11/2019
    1.78%
    Avg. UNII Per Share:
    As of 6/30/2018
    -$0.0077
    Total % Portfolio Effectively Leveraged:
    As of 10/11/2019
    23.00%

    Pricing Information

    Premium/Discount Information
    Past performance is no guarantee of future results.
    Premium/Discount Information

    As of 10/11/2019

    PeriodAvg Discount
    6 Month-12.67%
    1 Year-13.56%
    3 Year-13.19%
    5 Year-12.91%
    Z-Score

    As of 10/14/2019

    PeriodZStat
    3 Month-0.40
    6 Month-0.50
    1 Year0.40
    Pricing History
    Date NAV Premium / Discount

    Performance

    Calendar Year Total Returns

    As of 10/11/2019
    Category: Health/Biotech

    Past 20 Years

    Return YearPriceNAVCategory - PriceCategory - NAV
    YTD14.46%10.63%10.00%7.60%
    2018-5.75%-2.74%-5.60%-2.57%
    201715.05%13.11%19.49%17.19%
    2016-3.07%-3.63%-13.65%-12.78%
    20153.21%4.55%0.89%7.48%
    20146.08%10.48%20.97%25.78%
    201331.67%28.70%54.75%46.98%
    201236.80%25.62%30.90%24.10%
    201113.33%17.27%12.07%9.09%
    20105.97%9.15%15.84%9.71%
    200933.73%24.96%21.24%15.95%
    2008-28.55%-22.03%-25.63%-21.44%
    Past performance is no guarantee of future results.
    Annualized Total Returns

    Returns for periods less than one year are cumulative rather than annualized

    As of 10/11/2019
    Category: Health/Biotech

    Past performance is no guarantee of future results.

    Portfolio Characteristics

    Portfolio Characteristics
    Number of Holdings:
    As of 6/30/2019
    133
    Annual Portfolio Turnover:
    As of 12/31/2018
    32.40%
    Asset Allocation

    As of 12/31/2017 reported by Fund Sponsor

    Top Sectors

    As of 3/31/2017 reported by Fund Sponsor

    Sector%Portfolio
    Food 21.20%
    HealthCareProviders&Servi16.70%
    Pharmaceuticals 15.50%
    HealthCareEquipment&Suppl14.00%
    Food & Staples Retailing 8.30%
    Top Holdings

    As of 6/30/2019 reported by Fund Sponsor

    HoldingValue% Portfolio
    Nestle SA$7.25M2.26%
    HCA Holdings Inc$6.76M2.11%
    Actavis Inc$6.28M1.96%
    Kraft Foods, Inc.$5.93M1.85%
    Thermo Fisher Scientific Inc$5.87M1.83%
    Danone$5.85M1.82%
    Cigna Corp$5.83M1.82%
    Post Holdings Inc$5.72M1.78%
    WellPoint, Inc.$5.64M1.76%
    Abbott Laboratories$5.47M1.70%
    Merck & Co Inc$5.37M1.67%
    Country Allocation

    As of 12/31/2017 reported by Fund Sponsor

    Country% Portfolio
    USA 80.52%
    Japan 5.24%
    Switzerland 1.89%
    France 1.82%
    UK 1.49%
    Ireland 1.33%
    Germany 1.26%
    Italy 0.46%
    Hong Kong 0.37%
    Canada 0.22%
    China 0.13%
    Denmark 0.10%

    Closed-end fund historical distribution sources have included net investment income, realized gains, and return of capital. For more detailed information on the distributions of a specific fund, please visit the sponsor's website.

    NOTES:

    Distribution type sourced from Morningstar. For specific information about a fund's distribution sources, visit the fund sponsor's website.

    The following information applies to closed-end funds in general: Fund shares are not guaranteed or endorsed by any bank or other insured depository institution, and are not federally insured by the Federal Deposit Insurance Corporation. Shares of closed-end funds are subject to investment risks, including the possible loss of principal invested. There can be no assurance that fund objectives will be achieved. Closed-end funds frequently trade at a discount to their net asset value. NAV returns are net of fund expenses, and assume reinvestment of distributions.

    EWB-854124PR-E